Cardiorentis Competitors and Similar CompaniesClear all

Cardiorentis's competitors and similar companies include Travere Therapeutics, Ventria Bioscience, Immunicum and Forkhead BioTherapeutics.

	Cardiorentis Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.	Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.	Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.	Immunicum Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.	Forkhead BioTherapeutics Forkhead BioTherapeutics is a biotech company that develops transformative therapies.
Founding Date	Founding Date N/A	Founding Date 2011	Founding Date 1993	Founding Date 2002	Founding Date 2017
Type	Type Private	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Zug, CH HQ Freienbach, CH	Locations San Diego, US HQ Dublin, IE	Locations Junction City, US HQ Aurora, US	Locations Stockholm, SE HQ Leiden, NL	Locations New York, US HQ
Employees	Employees N/A	Employees 46293% increase	Employees 244% decrease	Employees 28	Employees 1
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.4 b	Valuation ($) N/A	Valuation ($) 49.3 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $490.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $10.3m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $480.4m (FY, 2025)	Gross profit N/A	Gross profit kr7.8m (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income ($25.5m) (FY, 2025)	Net income N/A	Net income (kr113.3m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 118.5m	Total funding raised $ 25m	Total funding raised $ 7.7m	Total funding raised N/A	Total funding raised N/A

For sources of this data, please see the company profile

View Company Profiles

Travere Therapeutics

San Diego, US

Employees

462

Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.

View company

Ventria Bioscience

Junction City, US

Employees

24↓ 4% decrease

Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.

View company

Immunicum

Stockholm, SE

Employees

Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.

View company